The store will not work correctly when cookies are disabled.
5-(3-Chloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA78310
PubChem CID: 10378955
Max Phase: Preclinical
Molecular Formula: C17H13ClN2
Molecular Weight: 280.76
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1cccc(C2=Cc3ccccc3C3=NCCN23)c1
Standard InChI: InChI=1S/C17H13ClN2/c18-14-6-3-5-13(10-14)16-11-12-4-1-2-7-15(12)17-19-8-9-20(16)17/h1-7,10-11H,8-9H2
Standard InChI Key: ONPNIDSLTDIICC-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
3.7667 -2.7375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2542 -3.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8042 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2917 -1.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7417 -2.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2542 -3.6417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7542 -2.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4042 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7000 -2.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2917 -3.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2917 -3.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3000 -2.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4542 -3.2500 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.6917 -1.6375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2042 -3.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2417 -1.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2917 -1.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5917 -2.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6917 -2.6917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7125 -2.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 2 1 0
6 2 2 0
7 4 1 0
8 3 1 0
9 8 2 0
10 1 1 0
11 10 1 0
12 9 1 0
13 12 1 0
14 8 1 0
15 5 1 0
16 7 1 0
17 14 2 0
18 17 1 0
19 15 2 0
20 16 2 0
6 11 1 0
5 7 2 0
12 18 2 0
20 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 280.76 | Molecular Weight (Monoisotopic): 280.0767 | AlogP: 3.91 | #Rotatable Bonds: 1 |
Polar Surface Area: 15.60 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.09 | CX LogP: 3.66 | CX LogD: 3.49 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.77 | Np Likeness Score: -0.58 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |